Evidence map›Paper›PMID 35911765›Full record

ArticleFrontiers in immunology2022

A Landscape Study on COVID-19 Immunity at the Single-Cell Level.

Rongguo Wei, Zheng Qin, Qi Huang, Lulu Liu, Fang Cheng, Songdong Meng, Lin Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rongguo WeiCAS Key Laboratory of Pathogenic Microbiology and Immunology, Center for Biosafety Mega-Science, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Zheng QinDepartment of Clinical Laboratory, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.
Qi HuangDepartment of Clinical Laboratory, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.
Lulu LiuCAS Key Laboratory of Pathogenic Microbiology and Immunology, Center for Biosafety Mega-Science, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Fang ChengCAS Key Laboratory of Pathogenic Microbiology and Immunology, Center for Biosafety Mega-Science, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Songdong MengCAS Key Laboratory of Pathogenic Microbiology and Immunology, Center for Biosafety Mega-Science, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Lin WangDepartment of Clinical Laboratory, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2019, the coronavirus (COVID-19) has outbroken continuously, spreading internationally and threatening the public health. However, it was unknown how the disorder at the single-cell level was associated with the pathogenesis of COVID-19. This study presented the disorders of macrophages, epithelial cells, CD8

Indexed as

COVID-19CD8-Positive T-LymphocytesCytokine Release SyndromeHumansInflammationSARS-CoV-2COVID-19cytokinesimmunitysignaling pathwaysingle-cell

Identifiers

PMID35911765
PMCPMC9334848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.